BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36557022)

  • 1. Comparative Outcomes of Robotic Radical Prostatectomy in Patients with Locally Advanced Prostate Cancer.
    Li PI; Chen SJ; Chen YH; Chen WC; Huang CP
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
    Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
    Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robot-assisted radical prostatectomy in the treatment of patients with clinically high-risk localized and locally advanced prostate cancer: single surgeons functional and oncologic outcomes.
    Shin TY; Lee YS
    BMC Urol; 2022 Apr; 22(1):49. PubMed ID: 35379195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate.
    Li X; Xi H; Cheng X; Yu Y; Zhang C; Wang G; Zhou X
    Front Endocrinol (Lausanne); 2023; 14():1123934. PubMed ID: 36843605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical Refinements in Superextended Robot-assisted Radical Prostatectomy for Locally Advanced Prostate Cancer Patients at Multiparametric Magnetic Resonance Imaging.
    Mazzone E; Dell'Oglio P; Rosiello G; Puliatti S; Brook N; Turri F; Larcher A; Beato S; Andras I; Wisz P; Pandey A; De Groote R; Schatteman P; De Naeyer G; D'Hondt F; Mottrie A
    Eur Urol; 2021 Jul; 80(1):104-112. PubMed ID: 32943260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation.
    Thompson JE; Sridhar AN; Shaw G; Rajan P; Mohammed A; Briggs TP; Nathan S; Kelly JD; Sooriakumaran P
    BMC Urol; 2020 Jul; 20(1):81. PubMed ID: 32611411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.
    Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009625. PubMed ID: 28895658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy.
    Ahn HK; Lee KS; Kim D; Rha KH; Hong SJ; Chung BH; Koo KC
    Yonsei Med J; 2020 Aug; 61(8):652-659. PubMed ID: 32734728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes.
    de Carvalho PA; Barbosa JABA; Guglielmetti GB; Cordeiro MD; Rocco B; Nahas WC; Patel V; Coelho RF
    Eur Urol; 2020 May; 77(5):628-635. PubMed ID: 30041833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcomes in prostate cancer patients treated with robot-assisted radical prostatectomy: results from a single institution series with more than 10 years follow up.
    Bianchi L; Gandaglia G; Fossati N; Larcher A; Pultrone C; Turri F; Selli C; de Groote R; de Naeyer G; Borghesi M; Schiavina R; Brunocilla E; Briganti A; Montorsi F; Mottrie A
    Minerva Urol Nefrol; 2019 Feb; 71(1):38-46. PubMed ID: 30547906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control.
    Hu JC; Gandaglia G; Karakiewicz PI; Nguyen PL; Trinh QD; Shih YC; Abdollah F; Chamie K; Wright JL; Ganz PA; Sun M
    Eur Urol; 2014 Oct; 66(4):666-72. PubMed ID: 24602934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Salvage Radiation Therapy on Survival, Functional Outcomes, and Quality of Life in Men with Persistent Prostate-specific Antigen After Robot-Assisted Radical Prostatectomy: Which Patient Benefits More?
    Özman O; Berrens AC; Pos F; van Leeuwen PJ; van der Poel H
    Pract Radiat Oncol; 2022; 12(6):e538-e546. PubMed ID: 35843543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic Outcomes Following Robot-Assisted Radical Prostatectomy for Clinical T3 Prostate Disease.
    Zilberman DE; Abu-Ghanem Y; Raviv G; Rosenzweig B; Fridman E; Portnoy O; Dotan ZA
    Isr Med Assoc J; 2021 Feb; 23(2):111-115. PubMed ID: 33595217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.